Snake antivenom research: The importance of case definition

Emergency Medicine Journal

Volumn 22, Issue 6, 2005, Pages 399-400

  Isbister, G K ^a  

^a CHARLES DARWIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SNAKE VENOM; SNAKE VENOM ANTISERUM;

ARTIFICIAL VENTILATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; ENVENOMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MEDICAL RESEARCH; METHODOLOGY; NEUROTOXICITY; NOTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SNAKE; SNAKEBITE; SPECIES DIFFERENCE; TREATMENT OUTCOME;

ADULT; ANTIVENINS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; NEUROTOXINS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SNAKE BITES; SNAKE VENOMS;

EID: 20344383763     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2004.022251     Document Type: Note

References (15)

1. White J, Warrell D, Eddleston M, et al. Clinical toxinology-where are we now? J Toxicol Clin Toxicol 2003; 41:263-76.
2. Chippaux J-P. Snake-bites: appraisal of the global situation. Bull World Health Organ 1998;76:515-24.
3. Theakston RDG, Warrell DA. Crisis in snake antivenom supply for Africa. Lancet 2000;356:2104.
4. Agarwal R, Aggarwal A N, Gupta D, Behera D, Jindal S K. Low dose of anti-snake venom is as effective as high dose in patients with severe neurotoxic snake envenoming. Emerg Med J 2005; 22:397-9.
5. Smalligan R, Cole J, Brito N, et al. Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms. BMJ 2004; 329:1129.
6. Caovilla JJ, Barros EJ. Efficacy of two different doses of antilonomic serum in the resolution of hemorrhagic syndrome resulting from envenoming by Lonomia obliqua caterpillars: a randomized controlled trial. Toxicon 2004;43:811-18.
7. Ariaratnam CA, Sjostrom L, Raziek Z, et al. An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell's viper (Daboia russelii russelii). Trans R Soc Trop Med Hyg 2001;95:74-80.
8. Abroug F, Elatrous S, Nouira S, et al. Serotherapy in scorpion envenomation: a randomised controlled trial. Lancet 1999;354:906-9.
9. Isbister GK, Graudins A, White J, et al. Antivenom treatment in arachnidism. J Toxicol Clin Toxicol 2003; 41:291-300.
10. Isbister GK. Data collection in clinical toxinology: debunking myths and developing diagnostic algorithms. J Toxicol Clin Toxicol 2002;40:231-7.
11. Isbister GK. Necrotic arachnidism: the mythology of a modern plague. Lancet 2004;364:549-53.
12. White J. Elapid snakes. In: Dart RC, ed. Medical toxicology. Philadelphia: Lippincott Williams & Wilkins, 2004:1566-78.
13. Theakston RD. An objective approach to antivenom therapy and assessment of first-aid measures in snake bite. Ann Trop Med Parasitol 1997;91:857-65.
14. Jelinek GA, Tweed C, Lynch D, et al. Cross reactivity between venomous, mildly venomous, and non-venomous snake venoms with the Commonwealth Serum Laboratories Venom Detection Kit. Emerg Med Australas 2004;16:459-64.
15. Theakston RD, Phillips RE, Warrell DA, et al. Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): efficacy and complications of therapy with Haffkine antivenom. Trans R Soc Trop Med Hyg 1990;84:301-8.